Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.52 |
| ▸ | GAA | P10253 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | KDR | P35968 | 1/20 | 0.46 |
| ▸ | TNNI3K | Q59H18 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | ERBB3 | P21860 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29141773 | 0.85 | KDR (0.43) | ALDH1A1SMN1; SMN2GAAHTTKDR | |
| SCHEMBL30781993 | 0.85 | KDR (0.43) | ALDH1A1SMN1; SMN2GAAHTTKDR | |
| SCHEMBL10101750 | 0.83 | PORCN (0.51) | ALDH1A1SMN1; SMN2GAAHTTPOLB | |
| SCHEMBL8211768 | 0.81 | POLB (0.47) | ALDH1A1SMN1; SMN2GAAHTTPOLB | |
| SCHEMBL21161286 | 0.80 | SMN1; SMN2 (0.49) | ALDH1A1SMN1; SMN2POLBMAPTFAAH | |
| SCHEMBL59779 | 0.80 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2GAAHTTPOLB | |
| SCHEMBL29141782 | 0.80 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2GAAHTTPOLB | |
| SCHEMBL30781986 | 0.80 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2GAAHTTPOLB | |
| SCHEMBL15890196 | 0.80 | NPC1 (0.59) | ALDH1A1SMN1; SMN2GAAHTTPOLB | |
| SCHEMBL16513943 | 0.80 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2GAAHTTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9951082-B2 | Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same | SHIONOGI & CO., LTD. (JP) | 2018-04-24 | — | — | US | disclosed |
| US-9951082-B2 | Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same | SHIONOGI & CO., LTD. (JP) | 2018-04-24 | — | — | US | disclosed |
| US-20180072748-A1 | CRYSTAL OF 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | SHIONOGI & CO., LTD. (JP) | 2018-03-15 | — | — | US | disclosed |
| US-20180072748-A1 | CRYSTAL OF 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | SHIONOGI & CO., LTD. (JP) | 2018-03-15 | — | — | US | disclosed |
| US-9902732-B2 | Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same | SHIONOGI & CO., LTD. (JP) | 2018-02-27 | — | — | US | disclosed |
| US-9902732-B2 | Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same | SHIONOGI & CO., LTD. (JP) | 2018-02-27 | — | — | US | disclosed |
| US-20170066774-A1 | CRYSTAL OF 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | SHIONOGI & CO., LTD. (JP) | 2017-03-09 | — | — | US | disclosed |
| US-20170066774-A1 | CRYSTAL OF 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | SHIONOGI & CO., LTD. (JP) | 2017-03-09 | — | — | US | disclosed |
| US-9464094-B2 | Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same | SHIONOGI & CO., LTD. (JP) | 2016-10-11 | — | — | US | disclosed |
| US-9464094-B2 | Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same | SHIONOGI & CO., LTD. (JP) | 2016-10-11 | — | — | US | disclosed |
| US-20160031896-A1 | CRYSTAL OF 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | SHIONOGI & CO., LTD. (JP) | 2016-02-04 | — | — | US | disclosed |
| US-20160024102-A1 | CRYSTAL OF 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | SHIONOGI & CO., LTD. (JP) | 2016-01-28 | — | — | US | disclosed |
| US-20160024102-A1 | CRYSTAL OF 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | SHIONOGI & CO., LTD. (JP) | 2016-01-28 | — | — | US | disclosed |
| US-9108975-B2 | Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same | SHIONOGI & CO., LTD. (JP) | 2015-08-18 | — | — | US | disclosed |
| US-9108975-B2 | Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same | SHIONOGI & CO., LTD. (JP) | 2015-08-18 | — | — | US | disclosed |
| EP-2639234-A1 | CRYSTALLINE 6,7-UNSATURATED-7-CARBAMOYL MORPHINANE DERIVATIVE, AND METHOD FOR PRODUCING SAME | Shionogi&Co., Ltd. (JP) | 2013-09-18 | — | — | EP | disclosed |
| US-20130231485-A1 | CRYSTAL OF 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | SHIONOGI & CO., LTD. (JP) | 2013-09-05 | — | — | US | disclosed |
| US-20130231485-A1 | CRYSTAL OF 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | SHIONOGI & CO., LTD. (JP) | 2013-09-05 | — | — | US | disclosed |
| US-20120083476-A1 | HETEROARYL-SUBSTITUTED SPIROCYCLIC DIAMINE UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE | JANSSEN PHARMACEUTICA NV (BE) | 2012-04-05 | — | — | US | disclosed |
| US-20120083476-A1 | HETEROARYL-SUBSTITUTED SPIROCYCLIC DIAMINE UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE | JANSSEN PHARMACEUTICA NV (BE) | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160024102-A1 | CRYSTAL OF 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | FASN, ALOX5, CASP7 | ALDH1A1 1010/4885SMN1; SMN2 3207/4885GAA 1749/4885 |
| US-20160031896-A1 | CRYSTAL OF 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | FASN, ALOX5, CASP7 | ALDH1A1 962/4885SMN1; SMN2 3024/4885GAA 1621/4885 |
| US-20130231485-A1 | CRYSTAL OF 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | FASN, ALOX5, CASP7 | ALDH1A1 1010/4885SMN1; SMN2 3207/4885GAA 1749/4885 |
| US-20180072748-A1 | CRYSTAL OF 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | FASN, ALOX5, CASP7 | ALDH1A1 1010/4885SMN1; SMN2 3207/4885GAA 1749/4885 |
| US-20170066774-A1 | CRYSTAL OF 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | FASN, ALOX5, CASP7 | ALDH1A1 1010/4885SMN1; SMN2 3207/4885GAA 1749/4885 |
| US-20120083476-A1 | HETEROARYL-SUBSTITUTED SPIROCYCLIC DIAMINE UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE | FAAH, FAAH2, DBH | ALDH1A1 709/4885SMN1; SMN2 1073/4885GAA 801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.